Physician profile
William Robert Still, III
NPI 1427314640
$1,184.68
in general payments reported to CMS, 2019-2025
18 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.46 · 2020: $38.50 · 2021: $138 · 2022: $266 · 2023: $228 · 2024: $209 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $265.48 | 2022-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $247.16 | 2021-2025 | Qelbree, Qelbree |
| Glaxosmithkline, LLC. | $96.96 | 2020-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $64.37 | 2019-2024 | Vaxneuvance, Gardasil, Vaxelis |
| Pfizer INC. | $60.69 | 2019-2025 | |
| Tris Pharma INC | $58.48 | 2021-2025 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $57.90 | 2024 | |
| Seqirus USA INC | $56.49 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent, Fluad |
| Sanofi Pasteur INC. | $45.89 | 2023-2025 | |
| Ultragenyx Pharmaceutical INC. | $40.30 | 2021-2022 | |
| Hologic Sales and Service, LLC | $32.70 | 2024 | Aptima |
| Adlon Therapeutics L.P. | $30.43 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $25.81 | 2024 | Flumist Quadrivalent |
| Sanofi-Aventis U.S. LLC | $25.58 | 2025 | |
| Baxter Healthcare | $20.74 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $20.74 | 2021 | |
| Collegium Pharmaceutical, INC. | $17.64 | 2025 | Jornay Pm |
| Abbvie INC. | $17.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Still listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.